As a Chartered Psychologist, child development researcher and author in the autism/ASD field, I frequently meet misperceptions of neurodiversity in relation to programmes for autism and health recovery. Somehow or other the belief has developed that to offer such help to an individual on the autistic spectrum is to deny their neurodiversity. In this blog I suggest a new way of looking at this subject…
Several studies published in recent months investigated the effects of cannabis-based products for treating autism. Although the studies were open-label and relatively small in scale, the overall results were overwhelmingly positive, with statistically significant improvements in social communication, language, restrictive/repetitive and challenging behaviours.
I hope that my journey in vision therapy will serve not only as a roadmap for people with mild autism to find their way out of the labyrinth of disability but as something that can provide clues to help those with more severe autism find their way to a life more fully lived.
When discussing autism—especially on the internet and in the media—there are way too many people who recklessly engage in false dichotomy. It’s a kind of extremism that gets us nowhere…I can say with 100% certainty that while I seek treatments for my child with autism, my acceptance of him is unconditional.
With the celebratory tone of autism awareness month, it’s easy to overlook common aspects of the autistic experience that no reasonable person would salute. To achieve a meaningful level of autism awareness, one that benefits all autistic individuals, we need to tell the stories that are hard to hear.
Recently in the UK, a “Neurodiversity Manifesto” has been shared by the Labour Party. It has five key principles, each of them lacking in nuance, unreflective of the lived experiences, and ignoring research data.
The Thinking Autism conference blends the opportunity to quench my thirst for autism knowledge, attend accessible social events where I can meet those unique individuals I have built a friendship with online, and the necessary support from dedicated members of the Thinking Autism team, all of whom have a lifetime of first-hand autism experience.
Today has been a day filled with anxiety and excitement in equal measure for this autistic humanoid. Driven by a love of puppetry, my interest in all things autism and a passion for the humble locomotive, I’ve broken my usually ironclad routine to make the 350 mile round trip to see All In a Row. For the uninitiated, it’s the somewhat controversial theatrical production featuring the severely autistic Laurence and his dysfunctional family…
A small double-blind, placebo-controlled trial shows dramatic effects of suramin as a treatment for autism. Improvements were seen in all three core features of autism: language, social interactions, and restricted or repetitive behaviours across multiple diagnostics in multiple tests in all who received the active treatments, absent in the placebo arm
Children with Congenital Heart Disease, Tuberous Sclerosis Complex, Duchenne Muscular Dystrophy, Ehlers-Danlos Syndrome, Neurofibromatosis Type 1 suffer high rates of autism. Everolimus, an mTOR inhibitor with strong neuro-inflammation attenuating effects, reduces core autism symptoms in some children with TSC, epilepsy and autism…
Privacy Policy | Terms and Conditions
© 2019 Thinking Autism | All rights reserved | Registered Charity: No. 1113628, Limited Company Registered in England: No. 5594787 | Registered address: International House, 24 Holborn Viaduct, London, EC1A 2BN | Contact tel. 07518131697